Celtic PLC Issued share capital

RNS Number : 1941U

Celtic PLC

27 June 2024

 

CELTIC PLC

Issued share capital

 

As a result of the conversion of 30,000 Convertible Cumulative Preference Shares of 60p each and 8,000 Convertible Preferred Ordinary Shares of 100p each, Celtic PLC's issued share capital as at 24 June 2024 was as follows:

 

94,768,565           Ordinary Shares of 1p each ("Ordinary Shares")                       

12,667,457           Convertible Preferred Ordinary Shares of 100p each ("CPO Shares")

15,689,724           Convertible Cumulative Preference Shares of 60p each ("CCP Shares")

689,187,817        Deferred Shares of 1p each

 

CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights. 

 

The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.

 

Application has been made for the admission of the 46,640 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, is expected to commence on 2 July 2024.

 

Enquiries:

 

Company

Christopher Duffy, Company Secretary                  0141 551 4313

 

Canaccord Genuity Limited

Simon Bridges, Nominated Adviser                          0207 523 8350

 

 

                               

 

 

                               

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEUBSARSSUNUAR